Early Diagnosis

2

Review clinical trials related to Early Diagnosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics

This study aims to develop and validate a test for detecting ovarian and endometrial cancers early. It relies on detecting somatic mutations that are associated with these cancers from a uterine pap test. A saliva sample is also collected that acts as an internal control and has the ability to detect deleterious germline mutations associated with common hereditary cancers (such as breast, ovarian, endometrial, colon, and pancreatic cancers). A machine learning classifier is then used to discriminate between cancer and benign disease.

Participants needed: 1,200
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: McGill UniversityUpdated: Jun 18, 2025Locations: 1
Eligibility criteria

Subjects should have suspected or confirmed cancer of the upper genital tract. [+1]

Status: Not yet recruiting

Establishment and Clinical Validation of a New Technique for Early Diagnosis of Diabetic Nephropathy

Diabetic kidney disease(DKD) is a leading cause of chronic kidney disease and end-stage renal disease across the world. Early identification of DKD is vitally important for the effective prevention and control of it. However, the available indicators are doubtful in the early diagnosis of DKD. This study aims to develop a novel system of multidimensional network biomarkers (MDNBs) to estimating early diabetic nephropathy, and further validating the performance of the novel systemin in prediction of the risk for early diabetic nephropathy by a nested case-control study.

Participants needed: 1,000
Trial details
Age: 20-80Biological sex: AllType: ObservationalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Jul 26, 2021
Eligibility criteria

Subjects who have signed informed consent. [+2]

Renal diseases caused by other causes, including primary and secondary; [+5]